{"schema_version":"secwatch.filing_event.v1","accession":"0000886163-23-000071","form_type":"8-K","ticker":"LGND","cik":"0000886163","company_name":"LIGAND PHARMACEUTICALS INC","filed_at":"2023-09-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:36.883695+00:00","generated_at":"2026-06-10T08:27:25.749685+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Ligand appoints Martine Zimmermann to board of directors","bullets":["Zimmermann appointed on Sept 22, 2023; serves as independent director.","SVP and Head of Regulatory Affairs and R&D Quality at Ipsen Biopharmaceuticals since Jan 2023.","Granted RSUs (2,285 shares) and options (11,345 shares at $59.08 strike), vesting over 3 years.","Also receives cash compensation per company's director compensation policy.","Board determined Zimmermann independent under Nasdaq rules; no material transactions with company."],"urls":{"canonical":"https://secwatch.observer/filing/0000886163-23-000071","json":"https://secwatch.observer/filing/0000886163-23-000071.json","markdown":"https://secwatch.observer/filing/0000886163-23-000071.md","text":"https://secwatch.observer/filing/0000886163-23-000071.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/886163/000088616323000071/0000886163-23-000071-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/886163/000088616323000071/lgnd-20230922.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T08:27:25.749685+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"c88e8d1727","claim":"Martine Zimmermann was appointed as member of Board at LIGAND PHARMACEUTICALS INC.","evidence_excerpt":"On September 22, 2023, the board of directors (the “Board”) of Ligand Pharmaceuticals Incorporated (the “Company”) appointed Martine Zimmermann as a member of Board.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/886163/000088616323000071/0000886163-23-000071-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"member of Board"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}